05:08 PM EDT, 08/07/2025 (MT Newswires) -- Ascendis Pharma ( ASND ) reported a Q2 loss late Thursday of 0.82 euros ($0.96) per diluted share, narrowing from a loss of 2.21 euros a year earlier.

Analysts polled by FactSet expected a loss of 1.29 euros.

Revenue for the quarter ended June 30 was 158 million euros, up from 36 million euros a year earlier.

Analysts surveyed by FactSet expected 144 million euros.

Shares of the company were up 3.5% in recent after-hours activity.

Price: 197.00, Change: +6.65, Percent Change: +3.49